PKU-24574-29120
2 vaccinations
1 coded response
14 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 956 / CA
- Registered
- 2021-06-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-05-22
Dose 1 — Pfizer-BioNTech
-
2021-06-12
Registered in v-safe
-
2021-06-12
Dose 2 — Pfizer-BioNTech
- 2021-06-12
-
2021-06-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-06-15
- 2021-06-16
- 2021-06-17
- 2021-06-18
- 2021-06-19
- 2021-06-26
- 2021-07-03
- 2021-07-12
- 2021-07-19
-
2021-07-24
Survey response — day 42, dose 2MedDRA: Diarrhoea, Nausea, Vomiting — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Nausea, vomiting, diarrheaMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2021-09-11
- 2022-06-12
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-05-22 | Pfizer-BioNTech | |
| 2 | 2021-06-12 | Pfizer-BioNTech |
Free text
Release 9 — day 42, dose 2
Symptoms: Nausea, vomiting, diarrhea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Diarrhoea | ✓ | · | ✓ |
| SD | Nausea | ✓ | · | ✓ |
| SD | Vomiting | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release